These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34330809)

  • 1. Assessing the Correlation Between
    Schierz JH; Sarikaya I; Albatineh AN; Sarikaya A
    J Nucl Med Technol; 2022 Mar; 50(1):43-48. PubMed ID: 34330809
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with
    Kalshetty A; Menon B; Rakshit S; Bhattacharjee A; Basu S
    J Nucl Med Technol; 2021 Sep; 49(3):235-240. PubMed ID: 34244223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Sink Effect in
    Gafita A; Wang H; Robertson A; Armstrong WR; Zaum R; Weber M; Yagubbayli F; Kratochwil C; Grogan TR; Nguyen K; Navarro F; Esfandiari R; Rauscher I; Menze B; Elashoff D; Delpassand ES; Herrmann K; Czernin J; Hofman MS; Calais J; Fendler WP; Eiber M
    J Nucl Med; 2022 Feb; 63(2):226-232. PubMed ID: 34049987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of parametric imaging and SUV imaging with [
    Chen R; Ng YL; Yang X; Zhu Y; Li L; Zhao H; Zhou Y; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):568-580. PubMed ID: 37792025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective head-to-head comparison of [
    Wang G; Li L; Zhu M; Zang J; Wang J; Wang R; Yan W; Zhu L; Kung HF; Zhu Z
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3126-3136. PubMed ID: 37233785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
    Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
    Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is SUV Corrected for Lean Body Mass Superior to SUV of Body Weight in
    Aksu A; Çapa Kaya G
    Mol Imaging Radionucl Ther; 2021 Oct; 30(3):144-149. PubMed ID: 34658229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging.
    Demirci E; Sahin OE; Ocak M; Akovali B; Nematyazar J; Kabasakal L
    Nucl Med Commun; 2016 Nov; 37(11):1169-79. PubMed ID: 27333090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihormonal-Treatment Status Affects
    Kluge K; Haberl D; Einspieler H; Rasul S; Gutschmayer S; Kenner L; Kramer G; Grubmüller B; Shariat S; Haug A; Hacker M
    J Nucl Med; 2023 Nov; 64(11):1730-1736. PubMed ID: 37734840
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Schmidkonz C; Cordes M; Schmidt D; Bäuerle T; Goetz TI; Beck M; Prante O; Cavallaro A; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1862-1872. PubMed ID: 29725716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA PET/CT Radioligand Infusions in Primary Prostatic Adenocarcinoma.
    Kohlbrenner R; Wu X; Nguyen HG; Cooperberg MR; Chakravarty T; Carroll PR; Hope TA
    Radiology; 2024 Aug; 312(2):e232544. PubMed ID: 39136560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Predicting Metastatic Disease in
    Chiu LW; Lawhn-Heath C; Behr SC; Juarez R; Perez PM; Lobach I; Bucknor MD; Hope TA; Flavell RR
    J Nucl Med; 2020 Dec; 61(12):1779-1785. PubMed ID: 32303599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary lymph-node staging with
    Corona-Montes VE; González-Cuenca E; Fernández-Noyola G; Olarte-Casas MA; Bobadilla-Salazar D; Medrano-Urtecho HM; Asimakopoulos AD
    Urol Oncol; 2021 Aug; 39(8):494.e1-494.e6. PubMed ID: 33223371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study comparing dominant intraprostatic lesion volume using Ga-68 prostate-specific membrane antigen PET-computed tomography and multiparametric MRI.
    Sasidharan A; Murthy V; Natarajan A; Agarwal A; Ranagrajan V; Gudi S; Singh S; Popat P
    Nucl Med Commun; 2020 Dec; 41(12):1291-1298. PubMed ID: 32941400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial Experience with Volumetric
    Schmuck S; von Klot CA; Henkenberens C; Sohns JM; Christiansen H; Wester HJ; Ross TL; Bengel FM; Derlin T
    J Nucl Med; 2017 Dec; 58(12):1962-1968. PubMed ID: 28522740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUV
    Baiocco S; Matteucci F; Mezzenga E; Caroli P; Di Iorio V; Cittanti C; Bevilacqua A; Paganelli G; Sarnelli A
    Mol Imaging Biol; 2020 Aug; 22(4):1070-1077. PubMed ID: 31758510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeatability of
    Seifert R; Sandach P; Kersting D; Fendler WP; Hadaschik B; Herrmann K; Sunderland JJ; Pollard JH
    J Nucl Med; 2022 May; 63(5):746-753. PubMed ID: 34446454
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Uprimny C; Kroiss AS; Decristoforo C; Fritz J; von Guggenberg E; Kendler D; Scarpa L; di Santo G; Roig LG; Maffey-Steffan J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):941-949. PubMed ID: 28138747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.